Demographic Aging And Strong Healthcare Demand Will Support Long-Term Rental Income Stability

Catalysts

About Aedifica/SA

Aedifica/SA is a pan-European healthcare real estate specialist focused on senior housing and elderly care properties let on long-term leases.

What are the underlying business or industry changes driving this perspective?

• Accelerating demographic aging in Aedifica’s core markets is tightening occupancy toward and above 90% in several countries. This should support sustained rent indexation and like-for-like rental growth, lifting revenue and EPRA earnings per share.
• Operators in key regions such as the U.K., Ireland, Finland and the Netherlands are seeing improving operating margins and stronger rent cover. This reduces counterparty risk and increases the room for contingent rents and uplifts, supporting net rental income and stabilising net margins.
• The refueled, fully pre-let development and forward funding pipeline, targeted at an average yield on cost of around 6.5% in high-demand care markets, should gradually re-rate the portfolio return profile and drive medium-term growth in rental income and earnings.
• Disciplined balance sheet management, with a targeted debt-to-asset ratio around 40% and largely fixed, low-cost, well-hedged debt, creates capacity to fund accretive investments and benefit from any compression in funding spreads. This supports future earnings and dividend growth.
• Improving transparency and performance data from operators, particularly in Finland and Germany, combined with structurally rising care needs, should enable better capital allocation into the most resilient assets and markets. This enhances portfolio quality, valuation resilience and long-term net asset value growth.

Assumptions

How have these above catalysts been quantified?

• Analysts are assuming Aedifica/SA's revenue will grow by 30.7% annually over the next 3 years.
• Analysts assume that profit margins will shrink from 156.9% today to 69.3% in 3 years time.
• Analysts expect earnings to reach €604.9 million (and earnings per share of €6.73) by about June 2029, down from €614.0 million today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting €765.0 million in earnings, and the most bearish expecting €523.7 million.
• In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 17.5x on those 2029 earnings, up from 9.6x today. This future PE is greater than the current PE for the GB Health Care REITs industry at 9.6x.
• Analysts expect the number of shares outstanding to grow by 7.0% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 7.69%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

• Rising interest costs over the medium term as low cost fixed debt matures after 2028 and is refinanced at higher spreads could erode the current 6 times interest cover ratio and compress EPRA earnings growth.
• A reversal in healthcare property valuations if yields stop edging up only from rent indexation and instead expand again, particularly in key markets like the U.K., Germany and the Netherlands, could weigh on the EUR 6.2 billion portfolio value and slow net asset value accretion.
• Operator specific issues, such as financial stress or restructurings at tenants like Colisee or smaller German operators, could lead to rent arrears, lease renegotiations or vacancies that undermine today’s near 100 percent portfolio occupancy and put pressure on net rental income and margins.
• Execution or regulatory setbacks in the Cofinimmo transaction, including delays from competition authorities or lower than expected synergies, could dilute shareholders without delivering the anticipated funding and cost benefits, limiting future earnings per share growth.
• Slower than expected demographic or policy support for elderly care in certain countries, for example lower than assumed fee increases or stricter staffing rules, could cap operator profitability and reduce the scope for further rent indexation and contingent rents, constraining revenue and EPRA earnings.

Valuation

How have all the factors above been brought together to estimate a fair value?

• The analysts have a consensus price target of €83.0 for Aedifica/SA based on their expectations of its future earnings growth, profit margins and other risk factors.
• However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €94.0, and the most bearish reporting a price target of just €70.0.
• In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be €873.3 million, earnings will come to €604.9 million, and it would be trading on a PE ratio of 17.5x, assuming you use a discount rate of 7.7%.
• Given the current share price of €70.55, the analyst price target of €83.0 is 15.0% higher. Despite analysts expecting the underlying business to decline, they seem to believe it's more valuable than what the market thinks.
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.